MET MetLife Inc.

INVESTOR ALERT: Kirby McInerney LLP Announces Investigation on Behalf of MetLife, Inc. Investors

The law firm of Kirby McInerney LLP announced today an investigation on behalf of MetLife, Inc. (“MetLife” or the “Company”) (NYSE: MET) investors concerning officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the MetLife page on our website at http://www.kmllp.com.

On January 29, 2018, MetLife announced it had postponed its earnings report and conference call related to its results for the fourth quarter and full year ended December 31, 2017. The Company cited “material weakness” in its financial reporting. MetLife also advised investors it expects to increase reserves in total between $525 and $575 million on a pre-tax basis to cover certain annuity recipients “who have been unresponsive or missing over time.”

On this news, the Company’s share price fell from $54.40 to $49.73 (a decline of $4.67) on January 30, 2018.

If you purchased or otherwise acquired MetLife securities, have information or would like to learn more about these claims, please contact Thomas W. Elrod of Kirby McInerney LLP at 212-371-6600, Toll-Free at 888-529-4787, or by email at [email protected] to discuss your rights or interests with respect to these matters without any cost to you.

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found at Kirby McInerney LLP’s website: http://www.kmllp.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

EN
30/01/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MetLife Inc.

Moody's Ratings rates MetLife’s subordinated debentures Baa1 (hyb)

New York , February 24, 2026 – Moody's Ratings (Moody's) has assigned a Baa1 (hyb) rating to the subordinated debentures issued by MetLife, Inc. (MetLife, NYSE: MET, senior debt A3). The debentures are being issued off MetLife's multi-purpose shelf registration statement filed in May 2025 and the pr...

Moody’s Ratings assigns ratings to MetLife’s shelf (senior unsecured a...

Moody’ s Ratings assigns ratings to MetLife’ s shelf. New York, January 5, 2026– Moody’ s Ratings has assigned provisional ratings to. MetLife, Inc.’ s shelf registration filed on May 16, 2025.

MarketLine Department
  • MarketLine Department

The Hartford Financial Services Group, Inc. - Mergers & Acquisitions (...

Summary Marketline's The Hartford Financial Services Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by The Hartford Financial Services Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisit...

Metlife Inc: 1 director

A director at Metlife Inc sold/gave away 30,684 shares at 0.000USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch